Defunct Company
Total Trials
9
As Lead Sponsor
As Collaborator
0
Total Enrollment
946
NCT02946125
Study of the Safety, Efficacy and PK of EYN-1601 in Dilation of the Pupil
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2016
Completion: Nov 30, 2016
NCT03480906
Eyenovia MiDD Usability Study
Phase: N/A
Start: Mar 12, 2018
Completion: Mar 17, 2018
NCT03751631
Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation
Phase: Phase 3
Start: Nov 15, 2018
Completion: Jan 11, 2019
NCT03751098
Start: Dec 1, 2018
Completion: Jan 21, 2019
NCT03942419
Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression
Start: Jun 3, 2019
Completion: Nov 20, 2024
NCT04657172
Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
Start: Dec 15, 2020
Completion: Mar 26, 2021
NCT04907474
Evaluation of Pupil Dilation Speed With the MAP Dispenser
Phase: Phase 4
Start: May 24, 2021
Completion: Jun 3, 2021
NCT05114486
Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults
Start: Nov 3, 2021
Completion: Sep 20, 2022
NCT06217796
Safety and Efficacy of Fixed Combination Phenylephrine-Tropicamide for Pupil Dilation
Start: Nov 28, 2023
Completion: Jan 9, 2024